From post

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients., , , , , , , , , и 2 other автор(ы). Clin Cancer Res, 12 (1): 131--138 (января 2006)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , и 27 other автор(ы). Clinical Cancer Research, (сентября 2014)The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models., , , , , , , , , и 193 other автор(ы). Nat Biotechnol, 28 (8): 827--838 (августа 2010)Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome., , , , , , , , , и . Genes Chromosomes Cancer, 45 (12): 1130--1142 (декабря 2006)Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , и 27 other автор(ы). Clin Cancer Res, 21 (8): 1904-1915 (апреля 2015)The development of stratification and segregation in a new scientific field: A study of collaboration among scientists in neuroblastoma research between 1975 and 2016., , и . Soc. Networks, (2023)Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome., , , , , , , , , и . Clin Cancer Res, 12 (17): 5118--5128 (сентября 2006)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , и 4 other автор(ы). J Clin Oncol, 24 (31): 5070--5078 (ноября 2006)Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma., , , , , , , , , и 3 other автор(ы). Genes Chromosomes Cancer, 53 (8): 639--649 (августа 2014)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , и 1 other автор(ы). Cancer Lett, 250 (2): 250--267 (июня 2007)